210 related articles for article (PubMed ID: 15661940)
1. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.
Siddiqui AA; Brouwer AE; Wuthiekanun V; Jaffar S; Shattock R; Irving D; Sheldon J; Chierakul W; Peacock S; Day N; White NJ; Harrison TS
J Immunol; 2005 Feb; 174(3):1746-50. PubMed ID: 15661940
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group.
Chaka W; Heyderman R; Gangaidzo I; Robertson V; Mason P; Verhoef J; Verheul A; Hoepelman AI
J Infect Dis; 1997 Dec; 176(6):1633-6. PubMed ID: 9395381
[TBL] [Abstract][Full Text] [Related]
3. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.
Jarvis JN; Casazza JP; Stone HH; Meintjes G; Lawn SD; Levitz SM; Harrison TS; Koup RA
J Infect Dis; 2013 Jun; 207(12):1817-28. PubMed ID: 23493728
[TBL] [Abstract][Full Text] [Related]
4. Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus-associated Cryptococcal Meningitis?
Beardsley J; Hoang NLT; Kibengo FM; Tung NLN; Binh TQ; Hung LQ; Chierakul W; Thwaites GE; Chau NVV; Nguyen TTT; Geskus RB; Day JN
Clin Infect Dis; 2019 Apr; 68(9):1494-1501. PubMed ID: 30169607
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
Jarvis JN; Meintjes G; Rebe K; Williams GN; Bicanic T; Williams A; Schutz C; Bekker LG; Wood R; Harrison TS
AIDS; 2012 Jun; 26(9):1105-13. PubMed ID: 22421244
[TBL] [Abstract][Full Text] [Related]
7. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
8. A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
Li A; Zhu W; Yin J; Huang X; Sun L; Hua W; Wang W; Zhang T; Dai L; Wu H
BMC Infect Dis; 2021 May; 21(1):500. PubMed ID: 34051748
[TBL] [Abstract][Full Text] [Related]
9. Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus.
Lortholary O; Dromer F; Mathoulin-Pélissier S; Fitting C; Improvisi L; Cavaillon JM; Dupont B;
J Infect Dis; 2001 Jan; 183(2):294-302. PubMed ID: 11110651
[TBL] [Abstract][Full Text] [Related]
10. Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection.
Singh N; Husain S; Limaye AP; Pursell K; Klintmalm GB; Pruett TL; Somani J; Stosor V; del Busto R; Wagener MM; Steele C
Transpl Immunol; 2006 Aug; 16(2):69-72. PubMed ID: 16860707
[TBL] [Abstract][Full Text] [Related]
11. Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.
Xu L; Xu Y; Zheng Y; Peng X; Yang Z; Cao Q; Xiang D; Zhao H
Clin Exp Immunol; 2021 Oct; 206(1):82-90. PubMed ID: 34287847
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis.
Mora DJ; Fortunato LR; Andrade-Silva LE; Ferreira-Paim K; Rocha IH; Vasconcelos RR; Silva-Teixeira DN; Nascentes GA; Silva-Vergara ML
PLoS One; 2015; 10(3):e0120297. PubMed ID: 25799044
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans.
Uicker WC; Doyle HA; McCracken JP; Langlois M; Buchanan KL
Med Mycol; 2005 Feb; 43(1):27-38. PubMed ID: 15712606
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman.
Einsiedel L; Gordon DL; Dyer JR
Clin Infect Dis; 2004 Oct; 39(8):e78-82. PubMed ID: 15486830
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis.
Jarvis JN; Meintjes G; Bicanic T; Buffa V; Hogan L; Mo S; Tomlinson G; Kropf P; Noursadeghi M; Harrison TS
PLoS Pathog; 2015 Apr; 11(4):e1004754. PubMed ID: 25853653
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.
Kawakami K; Hossain Qureshi M; Zhang T; Koguchi Y; Xie Q; Kurimoto M; Saito A
Cell Immunol; 1999 Oct; 197(1):55-61. PubMed ID: 10555996
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis.
Kornelisse RF; Hack CE; Savelkoul HF; van der Pouw Kraan TC; Hop WC; van Mierlo G; Suur MH; Neijens HJ; de Groot R
Infect Immun; 1997 Mar; 65(3):877-81. PubMed ID: 9038291
[TBL] [Abstract][Full Text] [Related]
18. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy.
Netea MG; Brouwer AE; Hoogendoorn EH; Van der Meer JW; Koolen M; Verweij PE; Kullberg BJ
Clin Infect Dis; 2004 Nov; 39(9):e83-7. PubMed ID: 15494899
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid cytokine and chemokine patterns correlate with prognosis of HIV-uninfected cryptococcal meningitis: A prospective observational study.
Jiang YK; Wang RY; Zhou LH; Cheng JH; Luo Y; Zhu RS; Qiu WJ; Zhao HZ; Wang X; Harrison TS; Zhu LP
Front Immunol; 2022; 13():993495. PubMed ID: 36032125
[TBL] [Abstract][Full Text] [Related]
20. Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy.
Mora DJ; Ferreira-Paim K; Andrade-Silva LE; Bragine T; Rocha IH; Ribeiro BM; Machado GH; Rodrigues Junior V; Silva-Teixeira DN; Meyer W; Silva-Vergara ML
PLoS One; 2017; 12(5):e0176304. PubMed ID: 28486489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
